# Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

> **NCT06461689** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 80 (actual)

## Conditions studied

- Prostate Cancer Metastatic

## Interventions

- **DRUG:** 177Lu-PSMA-617

## Key facts

- **NCT ID:** NCT06461689
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-31
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461689, "Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06461689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*